Photochemically-Mediated Inflammation and Cross-Presentation of Mycobacterium bovis BCG Proteins Stimulates Strong CD4 and CD8 T-Cell Responses in Mice

被引:3
|
作者
Waeckerle-Men, Ying [1 ,2 ]
Kotkowska, Zuzanna K. [1 ,2 ]
Bono, Geraldine [1 ,2 ]
Duda, Agathe [1 ,2 ]
Kolm, Isabel [1 ,2 ]
Varypataki, Eleni M. [1 ,2 ]
Amstutz, Beat [3 ]
Meuli, Michael [3 ]
Hogset, Anders [4 ]
Kuendig, Thomas M. [1 ,2 ]
Halin, Cornelia [5 ]
Sander, Peter [3 ,6 ]
Johansen, Pal [1 ,2 ]
机构
[1] Univ Zurich, Dept Dermatol, Zurich, Switzerland
[2] Univ Hosp Zurich, Zurich, Switzerland
[3] Univ Zurich, Inst Med Microbiol, Zurich, Switzerland
[4] PCI Biotech Holding ASA, Oslo, Norway
[5] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland
[6] Univ Zurich, Natl Ctr Mycobacteria, Zurich, Switzerland
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金
瑞士国家科学基金会;
关键词
PCI facilitates BCG vaccination; photochemical internalization; T cells; tuberculosis; vaccine; cross-presentation; GUINEA-PIG MODEL; TUBERCULOSIS VACCINE; PHAGOSOME MATURATION; PROTECTIVE IMMUNITY; INFECTION; IMMUNOGENICITY; CALMETTE; ARREST; INTERNALIZATION; IMMUNIZATION;
D O I
10.3389/fimmu.2022.815609
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Conventional vaccines are very efficient in the prevention of bacterial infections caused by extracellular pathogens due to effective stimulation of pathogen-specific antibodies. In contrast, considering that intracellular surveillance by antibodies is not possible, they are typically less effective in preventing or treating infections caused by intracellular pathogens such as Mycobacterium tuberculosis. The objective of the current study was to use so-called photochemical internalization (PCI) to deliver a live bacterial vaccine to the cytosol of antigen-presenting cells (APCs) for the purpose of stimulating major histocompatibility complex (MHC) I-restricted CD8 T-cell responses. For this purpose, Mycobacterium bovis BCG (BCG) was combined with the photosensitiser tetraphenyl chlorine disulfonate (TPCS2a) and injected intradermally into mice. TPCS2a was then activated by illumination of the injection site with light of defined energy. Antigen-specific CD4 and CD8 T-cell responses were monitored in blood, spleen, and lymph nodes at different time points thereafter using flow cytometry, ELISA and ELISPOT. Finally, APCs were infected and PCI-treated in vitro for analysis of their activation of T cells in vitro or in vivo after autologous vaccination of mice. Combination of BCG with PCI induced stronger BCG-specific CD4 and CD8 T-cell responses than treatment with BCG only or with BCG and TPCS2a without light. The overall T-cell responses were multifunctional as characterized by the production of IFN-gamma, TNF-alpha, IL-2 and IL-17. Importantly, PCI induced cross-presentation of BCG proteins for stimulation of antigen-specific CD8 T-cells that were particularly producing IFN-gamma and TNF-alpha. PCI further facilitated antigen presentation by causing up-regulation of MHC and co-stimulatory proteins on the surface of APCs as well as their production of TNF-alpha and IL-1 beta in vivo. Furthermore, PCI-based vaccination also caused local inflammation at the site of vaccination, showing strong infiltration of immune cells, which could contribute to the stimulation of antigen-specific immune responses. This study is the first to demonstrate that a live microbial vaccine can be combined with a photochemical compound and light for cross presentation of antigens to CD8 T cells. Moreover, the results revealed that PCI treatment strongly improved the immunogenicity of M. bovis BCG.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Ablation of CD8α+ dendritic cell mediated cross-presentation does not impact atherosclerosis in hyperlipidemic mice
    Bart Legein
    Edith M. Janssen
    Thomas L. Theelen
    Marion J. Gijbels
    Joep Walraven
    Jared S. Klarquist
    Cassandra M. Hennies
    Kristiaan Wouters
    Tom T.P. Seijkens
    Erwin Wijnands
    Judith C. Sluimer
    Esther Lutgens
    Martin Zenke
    Kai Hildner
    Erik A.L. Biessen
    Lieve Temmerman
    Scientific Reports, 5
  • [22] Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene
    Rowe, HM
    Lopes, L
    Ikeda, Y
    Bailey, R
    Barde, I
    Zenke, M
    Chain, BM
    Collins, MK
    MOLECULAR THERAPY, 2006, 13 (02) : 310 - 319
  • [23] CD4, CD8 AND THE ROLE OF CD45 IN T-CELL ACTIVATION
    LEDBETTER, JA
    DEANS, JP
    ARUFFO, A
    GROSMAIRE, LS
    KANNER, SB
    BOLEN, JB
    SCHIEVEN, GL
    CURRENT OPINION IN IMMUNOLOGY, 1993, 5 (03) : 334 - 340
  • [24] ACTIVATED CD4(+) AND CD8(+) T-CELL SUBSETS IN WEGENERS GRANULOMATOSIS
    SCHLESIER, M
    KASPAR, T
    GUTFLEISCH, J
    WOLFFVORBECK, G
    PETER, HH
    RHEUMATOLOGY INTERNATIONAL, 1995, 14 (05) : 213 - 219
  • [25] A REGULATORY ROLE FOR THE CD4 AND CD8 MOLECULES IN T-CELL ACTIVATION
    SCHREZENMEIER, H
    FLEISCHER, B
    JOURNAL OF IMMUNOLOGY, 1988, 141 (02): : 398 - 403
  • [26] TCR and notch signaling in CD4 and CD8 T-cell development
    Laky, K
    Fleischacker, C
    Fowlkes, BJ
    IMMUNOLOGICAL REVIEWS, 2006, 209 : 274 - 283
  • [27] First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus
    Petruccioli, Elisa
    Chiacchio, Teresa
    Pepponi, Ilaria
    Vanini, Valentina
    Urso, Rocco
    Cuzzi, Gilda
    Barcellini, Lucia
    Cirillo, Daniela Maria
    Palmieri, Fabrizio
    Ippolito, Giuseppe
    Goletti, Delia
    JOURNAL OF INFECTION, 2016, 73 (06) : 588 - 597
  • [28] PHOSPHORYLATION OF CD4 AND CD8 MOLECULES FOLLOWING T-CELL TRIGGERING
    BLUE, ML
    HAFLER, DA
    CRAIG, KA
    LEVINE, H
    SCHLOSSMAN, SF
    JOURNAL OF IMMUNOLOGY, 1987, 139 (12): : 3949 - 3954
  • [29] T-cell differentiation: Chromatin remodelling in CD4/CD8 regulation
    Zamoyska, R
    CURRENT BIOLOGY, 2003, 13 (05) : R189 - R191
  • [30] Homeostatic cytokines orchestrate the segregation of CD4 and CD8 memory T-cell reservoirs in mice
    Yang, Lili
    Yu, Yang
    Kalwani, Manorama
    Tseng, Tai-Wei Joy
    Baltimore, David
    BLOOD, 2011, 118 (11) : 3039 - 3050